KOJ performed in vitro and in vivo experiments. TJK performed physical tests and processed data.
Introduction
In vivo molecular imaging tools are critically important to understand the role played by cell trafficking in physiological and pathological processes 1 . Metastasis, for instance, is the single most important factor for predicting cancer survival, and targeting the metastatic cascade could significantly improve clinical outcomes 2 . Other incurable diseases have seen unprecedented progress thanks to the development of cellular therapies [3] [4] [5] , using stem cells or immune cells to target specific disease processes. In addition, many physiological processes such as hematopoiesis, immunity and embryonic development rely on the precisely orchestrated migration of cells throughout the body 6, 7 .
Molecular imaging tools can be used to estimate distribution of cells non-invasively, however, the information they provide relates to population averages and not individual cells. Unfortunately, many biological properties of cells become lost once averaged in this manner, including specific migration routes and kinetics of individual cells. Intravital microscopy methods can interrogate single-cell processes in vivo, but not at the scale of the whole body, and only in shallow tissues 8,9 . Additionally, magnetic resonance imaging (MRI) has demonstrated the capability to image single cells in vivo 10, 11 , but only in uniform-background anatomical sites such as the brain and the liver, and without sufficient temporal resolution to track moving cells.
Positron emission tomography (PET) is the only non-invasive imaging modality capable of detecting picomolar probe concentration in humans. Owing to its exceptional sensitivity, PET has been applied to a variety of cell tracking applications [12] [13] [14] but its potential for single-cell imaging has yet to be demonstrated. The concept of tracking moving particles using PET data originates from the field of chemical engineering, where the approach is used to estimate fluid and powder flows in complex opaque systems 15 . Recently, we developed a mathematical framework to extend this approach to the tracking of radiolabeled cells 16 , and validated the methodology experimentally using radioactive droplets 17 .
Here, we report the in vivo feasibility of "CellGPS", a methodology for tracking the trafficking of single cells inside a living subject with exquisite sensitivity (Fig. 1) . We use nanoparticles to stably and efficiently ferry 68 Ga radioisotope into live cells, then isolate single radiolabeled cells for injection into live mice. From the pattern of high-energy photons detected by PET, we infer, in real time, the position of these single cells with respect to anatomical landmarks derived from X-ray computed tomography (CT).
Results

Efficient method for cell radiolabeling
To radiolabel live cells with high efficiency, we harness the exceptional cargo-carrying capacity of mesoporous silica nanoparticles (MSNs). Due to the large surface area of their pores, these nanoparticles can efficiently transfer radionuclides into cells for real-time cell tracking applications. This study specifically considers 68 Ga, a radiometal used for PET imaging of neuroendocrine tumors and metastatic prostate cancer. Despite is relatively short half-life (67 minutes), high-specific-activity 68 Ga can be eluted from inexpensive 68 Ge generators, making it an increasingly popular isotope for clinical applications 18 . Here, we show that MSNs are able to carry 68 Ga into live cancer cells to achieve upwards of 100 Bq per single cell, an amount of radioactivity sufficient for real-time tracking applications 16, 17 . Although 100 Bq is truly a minute amount of radioactivity (it is less than 1 millionth of a standard PET dose), in terms of concentration, 100
Bq/cell is equivalent to 50 GBq/mL, about 100 times the concentration of 68 Ga eluted from a medical generator. The use of MSNs is therefore required to concentrate 68 Ga into cells and achieve sufficient labeling.
MSNs were sourced from Sigma-Aldrich (St Louis, MO) and physically characterized to reveal a spherical morphology with pore structure clearly visible on transmission electron micrographs ( Fig. 2a) . Hydrodynamic size distribution was estimated as 100-300 nm diameter ( Supplementary Fig. 1a ).
The MSNs were then labeled with 68 Ga according to a newly reported chelator-free method that exploits the oxophilicity of most radiometals 19 . To optimize the method, MSNs were reacted with (non-radioactive) 69 Ga under various conditions and the products were analyzed by electron microscopy (Supplementary Fig. 1b ). Energy dispersive spectroscopy measurements were used to map the elemental composition of the labeled nanoparticles and found that 69 Ga was uniformly distributed within the silica matrix ( Fig. 2b) . Other elements such as oxygen could be detected within the MSNs (Supplementary Fig. 1c ).
The MSNs were then successfully labeled with clinical-grade 68 Ga and purified to achieve >95% purity (thin-layer chromatography, Fig. 2c ). Labeling efficiency, measured by gamma counting, was found to be as high as 0.5 Bq/nanoparticle. To enhance cell loading and biocompatibility, 68 Ga-labeled MSNs were fused with a liposome-based transfection reagent 20 to coat their surface with a lipid bilayer, as confirmed by electron microscopy (Supplementary Fig. 1d ).
Passive uptake of 68 Ga-labeled MSNs was demonstrated in MDA-MB-231 breast cancer cells. The cells were incubated with 68 Ga-labeled MSNs (~25 MBq/ml) for 40 min, washed, then imaged by electron microscopy to reveal endocytosis of the particles into the cytosol (Fig 2d and   Supplementary Fig. 2a ). The MSNs were further labeled using a fluorescent dye (FITC), and their uptake was verified by fluorescence microscopy ( Fig. 2e) and quantified by flow cytometry (Fig. 2f ). Higher cell uptake was observed for lipid-coated MSNs compared to uncoated MSNs ( Supplementary Fig. 2b) . In quantitative terms, 95% of cells took up lipid-coated MSNs but only 20% took up uncoated MSNs ( Supplementary Fig. 2c and Supplementary Fig. 2d ).
Uptake of 68 Ga-labeled MSNs by adherent MDA-MB-231 cells was confirmed by radioluminescence microscopy (RLM), a method with single-cell imaging resolution 21 . Areas of high radioactivity coincided with fluorescent nuclear staining (NucBlue) and brightfield cell imaging, indicating localization of radioactivity within cells ( Fig. 2g ). Cell labeling with 68 Ga was more effective using lipid-coated MSNs than uncoated MSNs, and there was no detectable uptake of free 68 Ga (Supplementary Fig. 3a ). Furthermore, radiolabeling efficiency was relatively heterogeneous when analyzed on a single-cell basis. A few cells presented no detectable signal ( Supplementary Fig. 3b ). Radiolabel efflux by cells was measured by gamma counting and found to reach 50% after two hours ( Supplementary Fig. 4 ). Finally, cell labeling using 68 Ga-labeled MSNs resulted in a small (5-15%) but significant (P<0.001) decrease in cell viability for timepoints up to 24 h. At 48 h, cell damage was repaired, and no significant difference was observed ( Fig. 2h) . Non-radioactive MSNs did not significantly alter cell proliferation and viability.
Imaging weakly radioactive sources, such as single cells, is challenging because most PET scanners contain a small amount of naturally occurring radioactivity in their scintillation detectors 22 . Weak signals emitted by single cells may be drowned out by this intrinsic radioactivity background. We optimized the acquisition protocol and set the lower energy discriminator to 425 keV to achieve an optimal trade-off between background noise and sensitivity ( Supplementary Fig. 5 ). With these settings, an Inveon PET/CT scanner achieved a background coincidence rate of ~ 2.6 counts/s, equivalent to ~40 Bq distributed throughout the field of view.
To demonstrate the feasibility of imaging single cells using PET, radiolabeled MDA-MB-231 cells were diluted and dispensed in Terasaki plates for enumeration ( Fig. 2i) . Wells containing 1, 2, 5, and 10 cells were identified by fluorescence microscopy and their contents were transferred to a standard 96-well plate for PET imaging. The images, which were reconstructed using the standard 2D-OSEM algorithm, showed increasing PET signal with increasing cell number ( Fig. 2j) .
Importantly, a few single cells were clearly detectable by PET. Region-of-interest (ROI) analysis of the images confirmed the significant increase in ROI intensity with increasing cell number ( Fig.   2k ). Additionally, we performed quantitative gamma counting on another set of samples and measured a similar pattern of radioactivity uptake, with 30 Bq/cell on average and a range of 0-110 Bq/cell ( Fig. 2l ).
Static PET imaging of small cell populations in mice
To determine whether single cells could be imaged in vivo, approximately 100 MDA-MB-231 cells were labeled with 68 Ga-MSN (323 Bq in total) and DiO (fluorescent membrane dye), then injected via tail vein into a mouse. PET/CT images, acquired immediately thereafter, showed diffuse signal in both lungs ( Fig. 3a) and little detectable signal in other organs ( Supplementary   Fig. 6a ). Ex vivo gamma counting confirmed significant radioactivity in the lungs compared with liver and spleen ( Supplementary Fig. 6b ). To confirm the arrest of the cells in the lungs, lung tissues were excised, and DiO-labeled cancer cells were visualized by fluorescence microscopy ( Supplementary Fig. 6c & 6d) . The arrest of cancer cells in the lungs was confirmed in another mouse injected with 10 6 DiO-labeled cells (Supplementary Fig. 6e ).
Other injection routes were also investigated. A bolus of 10 radiolabeled cells (118 Bq in total) was injected in right thigh of a mouse and imaged with PET/CT images to reveal focal signal at the injection site ( Fig. 3b) , with no significant radioactivity elsewhere ( Supplementary Fig. 7a) .
Similarly, 10 cells were injected intraperitoneally in the abdomen (94 Bq; Supplementary Fig. 7b ) and in the footpad (84 Bq; Supplementary Fig. 7c ). In all cases, the PET signal was confined to the injection site.
Using the same workflow, we proceeded to image single cells in mice using PET. A set of radiolabeled single cells was isolated in Terasaki plates through limiting dilution. Then, using a portable radiation survey meter, we rapidly screened dozens of cells to find single cells with high radioactivity that could be injected into mice. Because 68 Ga-MSN uptake is variable, this screening process is critical to ensure that the candidate cell has sufficient radioactivity for in vivo tracking.
In a first experiment, a single radiolabeled single cell (27 Bq) was injected into the footpad of a mouse. PET/CT images, acquired minutes after injection, depicted strong focal signal near the injection site ( Fig. 3c) , with no significant PET signal in other organs (Supplementary Fig. 7d ).
These images show that PET can image single cells, which are much smaller than the resolution of the scanner. Indeed, the diameter of the PET signal was approximately 1.7 mm, which is consistent with the spatial resolution of the Inveon PET scanner.
Next, isolated single cells (20-70 Bq) were injected via a butterfly catheter into the tail vein of mice (n=3). PET acquisition was started either before (n=2) or after (n=1) single-cell injection. All injected mice presented a single locus of radiotracer accumulation in their lungs on PET/CT images (Fig. 3d) . The major organs were then removed and imaged again ex vivo (Fig. 3e) .
Consistent with in vivo findings, focal uptake was observed in the lungs (Fig. 3f) . Ex vivo gamma counting further measured 7-35 Bq in the lungs and less than 2 Bq in other organs ( Fig. 3g) .
Finally, the lungs were dissected in an attempt to localize the arrested cancer cell. The tissue was chopped into five pieces; of these, only one contained significant radioactivity ( Supplementary   Fig. 8 ). We repeated this process until radioactive signal was confined to a piece of lung tissue smaller than 1 mm. We then imaged the tissue sample by widefield fluorescence microscopy and identified a single speck of enhanced red fluorescence ( Fig. 3h) . Finally, we imaged the area by confocal microscopy and found a single locus positive for blue and red fluorescence, which we attribute to NucBlue and DiI staining of the injected cell ( Fig. 3i) . Green fluorescence, imaged as a negative control, was negative for the identified locus.
Dynamic tracking of single cells in mice
Cell trafficking is a dynamic process. Real-time tracking could help shed light on kinetics and migration routes of trafficking cells. Here, we demonstrate that PET data can be used to dynamically track the position of a single cell in vivo. By design, PET scanners record data in the list-mode format, a datafile that contains, in a long list, the attributes of every photon coincidence event detected by the scanner, including time of detection, photon energy, and position of the detector elements involved. In the conventional PET workflow, list-mode data are binned into a stack of 2D sinograms, then reconstructed to form a tomographic image using an algorithm called OSEM (ordered-subset expectation-maximization). In general, this approach does not permit dynamic tracking of single cells. Various particle tracking methods have been developed to estimate the time-varying position of a moving source directly the raw list-mode data, but their application has been limited to chemical engineering systems 15 . Our recent work modeled the trajectory of the cell as a cubic B-spline and computed its time-varying position by solving a convex optimization problem 16 .
The feasibility of tracking a moving cell was demonstrated first by enclosing a single radiolabeled MDA-MB-231 cell (36 Bq) into a 1.5 ml conical tube. Static PET/CT imaging detected a radioactive signal from the single cell inside the tube (Supplementary Fig. 9a) . A list-mode acquisition was then performed, during which the tube was slowly moved along the axis of the scanner in one direction, then in the opposite direction, and finally removed from the scanner bore.
The algorithm was able to compute the position of the object, even as it was being moved ( Supplementary Fig. 9b and Supplementary Video 1) . Furthermore, the count rate ( Supplementary Fig. 9c ) dropped (from 6.4 to 4.7 counts/s) once the vial had been removed from the scanner, suggesting that the cell contributed approximately 1.7 counts/s to the overall PET count rate, equivalent to 24 Bq (assuming 7% coincidence detection sensitivity).
To further validate this approach, we coiled a length of plastic tubing around a 3D-printed cylinder to form a helical test phantom (Fig. 4a) . The phantom was placed in the bore of a PET scanner and a single MDA-MB-231 cell (67 Bq) was flowed at a speed of 1.36 mm/s through the tubing using a syringe pump. List-mode PET data were acquired for 10 min and then reconstructed into a 3D spline trajectory. Unlike the conventionally reconstructed image, which showed no localized signal ( Supplementary Fig. 10a ), the dynamically reconstructed trajectory matched the helical shape of the phantom, including its pitch and diameter (Fig. 4b) . The single cell could also be seen exiting the scanner through the center of the phantom (Supplementary Video. 2) . We quantified the localization error (defined here as the root-mean square deviation from the ideal helical trajectory) and found it to be less than 5 mm (Supplementary Fig. 10b ). Finally, we estimated the velocity of the cell according to its reconstructed trajectory ( Fig. 4c) . At its peak, the cell moved at the same speed as the injected bolus, although, at times, the cell slowed down significantly, possibly because it interacted with the walls of the plastic tubing.
We then applied this dynamic tracking methodology to single cells injected into live mice. First, the trajectories of static cells were reconstructed. For the previous mouse injected in the footpad, the single cell (27 Bq) remained at the injection site for the duration of the 10 min PET acquisition ( Supplementary Fig. 11 and Supplementary Video. 3). For another mouse injected intravenously before the start of PET/CT acquisition, the radiolabeled cell (30 Bq) was correctly located in the mouse lung and no significant motion was observed during the 10 min acquisition ( Supplementary Fig. 12 and Supplementary Video. 4), suggesting that the cell did not migrate after its arrest in the lung. For these static cells, the 3D position reconstructed using the splinebased tracking algorithm matched the PET images reconstructed through conventional OSEM.
Finally, real-time tracking was demonstrated by tracking a single cell (70 Bq) continuously, from its injection into the tail vein (via a catheter; Fig. 4d ) to its arrest in the lungs. We monitored the arrival of the radiolabeled cell into the field of view of the scanner by tracking the rate of coincidence events as a function of time ( Fig. 4e) . Initially, the detected counts were due to natural background radioactivity. Once the cell entered the bore of the scanner (at t = 85 s), the count rate jumped from 2 cps to 21 cps, and cell tracking was initiated. To visualize the pattern of coincident gamma ray detection, we charted the recorded coincidence events (shown as blue lines) and the reconstructed cell trajectory (yellow curved line) over a cross-sectional CT image of the mouse (Fig. 4f) . The dynamic migration of the cell is also shown in Supplementary Video 5 and 6.
According to the reconstructed trajectory, the single cell arrested in the lungs within 3 s of intravenous injection. The location of the arrested cell matched the focal signal seen on conventional PET/CT imaging (Supplementary Fig. 13a ). The reconstructed cell migration route is also displayed as a transaxial view ( Fig. 4g) and combined with a surface-rendered model of the mouse bony anatomy (Fig. 4h ). An analysis of the reconstructed trajectory estimated the velocity of the cell at around 50 mm/s immediately post-injection (Supplementary Fig. 13c ). For reference, the velocity of venous blood in the inferior vena cava in mice is approximately 40 mm/s, according to a previous study using magnetic resonance imaging 23 . Finally, as a control, PET data acquired from ex vivo organs were reconstructed. The algorithm localized the single cell to the excised lungs, and no motion was observed, apart from random fluctuations due to physical noise (rootmean-square error, RMSE <0.45 mm; Supplementary Fig. 13d and Supplementary Video 7) .
Discussion
One of the major findings of this study is that PET is sufficiently sensitive to image static single cells labeled with 20 Bq/cell or more of radioactivity. Standard OSEM reconstruction produced surprisingly good images of single cells in vivo after 10 min of acquisition with an optimized energy window that removes background noise. Labeled cells manifest in PET images as small hot spots (diameter ~1.7 mm) in an otherwise blank background. One advantage of tracking individual cells (as opposed to bulk populations) is that the presence of cells in an organ can be assessed unambiguously because, unlike single cells, unbound tracer does not produce focal uptake.
Different numbers of cells could be imaged with this approach, but single-cell enumeration will only be possible where cells are sufficiently distant from one another. More advanced image reconstruction methods may provide advantages for single-cell imaging and should be investigated.
The second important finding of this study is that single migrating cells can be tracked dynamically directly from list-mode PET data. From a technical standpoint, dynamic cell tracking is vastly more challenging than static cell imaging, especially at high velocities. Our approach infers the position of the cell by fitting a 3D cubic B-spline to the dynamic pattern of gamma ray interactions recorded by the PET scanner. The method is flexible and can be tuned to achieve either high accuracy or high reactivity, which are two competing objectives. For instance, in Fig. 4 d-h, a single cell (70 Bq) was tracked from the tail vein to its arrest 3 s later in the lungs. During the first 5 s of tracking, the algorithm was tuned to be highly reactive to cell motion to accommodate the high velocity of the cell. Previous analyses indicate that robust tracking is achievable on the condition that ratio of the cell velocity (V) to its activity (A) does not exceed 0.1 mm/s/Bq 17 . Physically, V/A represents the average distance traveled by the cell in between radioactive decays. In this example, the initial velocity of the cell was estimated to be around 50 mm/s. Based on the V/A criterion, a single-cell activity of 500 Bq-considerably higher than 70 Bq-would be required for accurate tracking. The reconstructed trajectory of the cell during the first 5 s of tracking should therefore be interpreted as qualitative rather than quantitative. Once the cell arrested in the lungs, the algorithm was adjusted to maximize localization accuracy. With these settings, the variability in the estimated position of the cell over time was ~ 0.4 mm RMSE, considerably better than the spatial resolution of the scanner. The phantom data (Fig. 4 a-c) also illustrate the importance of the V/A criterion. In that experiment, a V/A ratio of 0.02 mm/s/Bq was achieved, enabling robust dynamic tracking of the moving single cell.
For greater cell throughput, the CellGPS methodology could be extended to enable tracking of multiple cells simultaneously. A previous study simultaneously tracked, in vitro, 16 yeast cells labeled with 18 F (32 Bq/cell). Individual cells could be resolved and slow diffusion of the cells in the medium was observed 24 . Tracking multiple cells will likely be possible provided that the following conditions are met: cells are separated from each other by at least 2-3 times the spatial resolution of the scanner; at any given time, no more than one cell moves rapidly within the imaged subject; and cells are administered one-by-one such that they can be individually tracked from the injection site to the initial site of arrest. In the case of cellular therapies, where millions of cells are injected, it may be possible to label and track a small subset of cells using the CellGPS methodology.
Robust tracking of single cells using PET requires scanners with low background and high sensitivity. Preclinical PET scanners have much higher sensitivity than human-sized scanners because their bore almost completely surrounds the subject. However, almost all PET scanners suffer from non-negligible background noise arising from natural radioactivity within their lutetium oxyorthosilicate (LSO) detectors. Improved tracking performance can be achieved using PET detectors built from scintillator materials that do not contain significant radioactivity, such, for instance, bismuth germanate (BGO). In a previous study, we assessed that the amount of radioactivity required per cell for tracking could be reduced three-fold through the use of lownoise BGO detectors 17 .
With a half-life of 67 minutes, 68 Ga is suitable for short-term tracking applications. For long-term tracking, MSNs can be labeled with other radiometals, such as 64 Cu (12 h half-life) and 89 Zr (78 h half-life) 19 . However, these long-lived isotopes may cause higher radiotoxicity to the labeled cells and they may also affect the biological fate of the labeled cells. Most of the biological damage is wreaked by positrons, which upon emission move at relativistic speeds through cells and ionize biomolecules along their path. Fortunately, the physical range of positrons is much greater than the typical cell diameter, therefore, most of the damage is outside the labeled cells. To mitigate radiotoxicity, biological radioprotectants could be loaded into cells prior to radiolabeling. These compounds reduce oxidative damage by scavenging free radicals and reactive oxygen species.
In conclusion, CellGPS represents an entirely novel workflow for tracking individual cells in vivo.
The methodology was used to show that MDA-MB-231 cancer cells injected intravenously in mice arrest in the lung within 3 s of their injection and travel at a velocity of up to 50 mm/s. This novel workflow could have a number of significant applications. For instance, it could be used to investigate the early stages of the metastatic cascade. Considerable evidence suggests that tumor cells combine with platelets to form microemboli complexes in the vasculature and that these complexes play a critical role in the formation of metastases 25 . Another significant
Online Methods
Cell Line and Cell Culture
The MDA-MB-231 cell line (human invasive ductal carcinoma) was obtained from Cell Biolabs in 
MSN Radiolabeling
The MSNs were labeled with 68 Ga using a chelator-free reaction method 19 . First, the nanoparticles were activated in ethanol overnight. Then, 4.5 µg of MSNs were added to a 1.5 ml tube containing 
Fluorescent Labeling of MSNs and Cells
The MSNs were labeled with FITC (fluorescein isothiocyanate isomer I; Sigma-Aldrich, St Louis, MO, USA), via formation of thiourea bond with NH2 functional groups on the MSN surface.
Approximately 1 mg of MSNs were mixed with a solution of 1 ml FITC (0.1 mg/ml) and incubated at room temperature for 1 hr. The mixture was then washed three times with fresh PBS and centrifuged at 14,000 rpm for 1 min to remove excess FITC. For validation purpose, cells were labeled by incubation at 37°C for 15 min with fluorescent lipophilic tracers such as DiO (Invitrogen, Carlsbad, CA, USA; green fluorescence; Ex: 484 nm, Em: 501 nm) or DiI (Invitrogen, Carlsbad, CA, USA; red fluorescence; Ex: 565 nm, Em: 594 nm). Additionally, nuclear staining was performed by incubation with NucBlue Live (ReadyProbes; Thermo Fisher Scientific, Waltham, MA, USA) for 5 min at 37°C.
Fluorescent Imaging and Flow Cytometry of MSN Uptake in Cells
MDA-MB-231 cells (2× 10 5 cells/plate) were incubated with MSNs or lipid-coated MSNs (4.5 g/mL) for 40 min. To characterize cell uptake of MSNs, the treated cells were fixed with 2% glutaraldehyde. The cells were subsequently deposited on 300-mesh carbon/formvar-coated copper grids and imaged by TEM as previously described. Similarly, the uptake of FITC-labeled MSNs was imaged by fluorescence microscopy (EVOS FL, ThermoFisher Scientific, Santa Clara, CA, USA) and further quantified by flow cytometry (BD FACSAria Fusion sorter, BD Bioscience, San Jose, CA, USA).
Cell Viability Assay
MDA-MB-231 cells were seeded in 96-well plates (2.5 × 10 3 cells/well). To evaluate the cytotoxicity of MSNs in cells, cell viability was determined at various time points, up to 48 h after treatment with 4.5 g/mL of lipid-coated MSNs (with or without 68 Ga labeling). The cells were incubated with CCK-8 (Cell Counting Kit-8) solution (Sigma-Aldrich, St Louis, MO, USA) and, after 1 h, mean optical density (OD) was measured at 450 nm using a GloMax multi-detection system (Promega, Madison, WI, USA). Blank measurements were acquired and subtracted.
Radioluminescence Microscopy
A custom-built radioluminescence microscope (RLM) was used to image the uptake of 68 Galabeled MSNs by cells. The construction and use of the microscope is described in a previous publication 21 
Radioactivity Measurement using D-PET and Gamma Counter
Cells labeled with 68 Ga-MSN were manually sorted into single cells through limiting dilution in Terasaki plates 30 . Fluorescence microscopy was used to enumerate the cells in each well. Wells For dynamic tracking of single cells, a butterfly catheter was inserted into the mouse tail vein, and single radiolabeled cells were injected while PET data were acquired. The list-mode data file was imported into MATLAB and analyzed to identify the time at which the cell entered the scanner.
The spline knots were then defined to achieve a higher density of knots during the initial migration of the cell and a lower density of knots after its arrest. Spline knots were defined at T = 85, 86.3, 87.7 and 90 s initially, then every 23 seconds thereafter. This protocol allowed us to track the cell during its rapid migration while still achieving high tracking accuracy for the remainder of the scan. Given the high density of knots in the initial phase of the trajectory, the position of the cell is approximate and should be interpreted as a qualitative estimate (see Discussion).
Ex Vivo Validation Studies
To identify the organs in which single cells have arrested, ex vivo tissues were imaged using PET (same parameters as for in vivo imaging) and radioactivity was measured using gamma counting.
Whole lungs were cut into small chunks and individually measured with the gamma counter.
Finally, the tissue chunks were imaged using a SteREO Discovery V20 microscope (Carl Zeiss, Thornwood, CA, USA) and Zeiss LSM-700 confocal microscope (Carl Zeiss, Thornwood, CA, USA) to confirm fluorescence of DiO/DiI-labeled cells in ex vivo tissues.
Statistical Analysis
All data are presented as mean ± standard deviation. P values < 0.05 were considered to be statistically significant and were obtained using Student's t-test (two-tailed, unpaired samples).
Data availability
Raw PET/CT data (list-mode format) that support the findings of this study are available from the corresponding author upon request. All other data are available within the paper and its supplementary information files. 
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